Skip to main content
Top
Published in: Digestive Diseases and Sciences 1/2016

01-01-2016 | Original Article

Functional Gastrointestinal Symptoms Are Associated with Higher Serum Total IgE Levels, but Less Atopic Sensitization

Authors: Ellen Johanne Vara, Cecilie Svanes, Trude D. Skorge, Aud Berstad, Erik Florvaag, Debbie Jarvis, Ernst Omenaas, Marie Waatevik, Ane Johannessen, Gülen Arslan Lied

Published in: Digestive Diseases and Sciences | Issue 1/2016

Login to get access

Abstract

Background

The relation of gastrointestinal (GI) complaints to IgE-mediated allergy is not well understood. Increased numbers of “IgE-armed” mast cells have been observed in duodenal mucosa of patients with functional GI complaints.

Aims

To explore whether total IgE and atopic sensitization were associated with functional GI complaints.

Methods

Levels of serum total and specific IgE and GI complaints were measured in 161 patients and in a general population sample of 478 persons. Standard inhalant allergens were measured in the patient group, and selected inhalant allergens in the general population. GI complaints were assessed by two standardized questionnaires. The associations between GI complaints and total IgE were analyzed in multiple regression models.

Results

GI complaints were positively associated with higher total IgE levels (all: b = 0.028, p = 0.012; patient group: b = 0.038, p = 0.072; general population: b = 0.038, p = 0.005), but negatively associated with atopic sensitization (all: b = −11.256, p = 0.181; patient group: b = −85.667, p < 0.001; general population: b = −14.394, p = 0.083). The relationship between total IgE and GI complaints was consistent among sensitized and non-sensitized persons, among men and women, and across age groups.

Conclusion

Serum total IgE was positively associated with GI complaints, while atopic sensitization was inversely associated with GI complaints. This suggests that IgE-mediated immunology plays a role in the pathophysiology of functional GI complaints. The biological mechanisms reflected in higher total IgE levels, but less atopic sensitization, warrant further studies.
Appendix
Available only for authorised users
Literature
1.
go back to reference Chang L. Review article: epidemiology and quality of life in functional gastrointestinal disorders. Aliment Pharmacol Ther. 2004;20:31–39.PubMedCrossRef Chang L. Review article: epidemiology and quality of life in functional gastrointestinal disorders. Aliment Pharmacol Ther. 2004;20:31–39.PubMedCrossRef
2.
go back to reference Chang L, Heitkemper MM. Gender differences in irritable bowel syndrome. Gastroenterology. 2002;123:1686–1701.PubMedCrossRef Chang L, Heitkemper MM. Gender differences in irritable bowel syndrome. Gastroenterology. 2002;123:1686–1701.PubMedCrossRef
3.
go back to reference Lied GA. Indication of immune activation in patients with perceived food hypersensitivity. Dig Dis Sci. 2014;59:259–266.PubMedCrossRef Lied GA. Indication of immune activation in patients with perceived food hypersensitivity. Dig Dis Sci. 2014;59:259–266.PubMedCrossRef
4.
go back to reference Park MI. Is there a role of food allergy in irritable bowel syndrome and functional dyspepsia? A systematic review. Neurogastroenterol Motil. 2006;18:595–607.PubMedCrossRef Park MI. Is there a role of food allergy in irritable bowel syndrome and functional dyspepsia? A systematic review. Neurogastroenterol Motil. 2006;18:595–607.PubMedCrossRef
5.
go back to reference Lillestol K, Helgeland L, Arslan Lied G, et al. Indications of ‘atopic bowel’ in patients with self-reported food hypersensitivity. Aliment Pharmacol Ther. 2010;31:1112–1122.PubMed Lillestol K, Helgeland L, Arslan Lied G, et al. Indications of ‘atopic bowel’ in patients with self-reported food hypersensitivity. Aliment Pharmacol Ther. 2010;31:1112–1122.PubMed
6.
go back to reference Bartra J, Sastre J, del Cuvillo A, et al. From pollinosis to digestive allergy. J Investig Allergol Clin Immunol. 2009;19:3–10.PubMed Bartra J, Sastre J, del Cuvillo A, et al. From pollinosis to digestive allergy. J Investig Allergol Clin Immunol. 2009;19:3–10.PubMed
7.
go back to reference Matsui EC, Sampson HA, Bahnson HT, et al. Allergen-specific IgE as a biomarker of exposure plus sensitization in inner-city adolescents with asthma. Allergy. 2010;65:1414–1422.PubMedPubMedCentralCrossRef Matsui EC, Sampson HA, Bahnson HT, et al. Allergen-specific IgE as a biomarker of exposure plus sensitization in inner-city adolescents with asthma. Allergy. 2010;65:1414–1422.PubMedPubMedCentralCrossRef
8.
go back to reference Lied GA, Lillestol K, Lind R, et al. Perceived food hypersensitivity: a review of 10 years of interdisciplinary research at a reference center. Scand J Gastroenterol. 2011;46:1169–1178.PubMedCrossRef Lied GA, Lillestol K, Lind R, et al. Perceived food hypersensitivity: a review of 10 years of interdisciplinary research at a reference center. Scand J Gastroenterol. 2011;46:1169–1178.PubMedCrossRef
9.
go back to reference Tobin MC, Moparty B, Farhadi A, et al. Atopic irritable bowel syndrome: a novel subgroup of irritable bowel syndrome with allergic manifestations. Ann Allergy Asthma Immunol. 2008;100:49–53.PubMedCrossRef Tobin MC, Moparty B, Farhadi A, et al. Atopic irritable bowel syndrome: a novel subgroup of irritable bowel syndrome with allergic manifestations. Ann Allergy Asthma Immunol. 2008;100:49–53.PubMedCrossRef
10.
go back to reference Pires GV, Souza HS, Elia CC, et al. Small bowel of patients with asthma and allergic rhinitis: absence of inflammation despite the presence of major cellular components of allergic inflammation. Allergy Asthma Proc. 2004;25:253–259.PubMed Pires GV, Souza HS, Elia CC, et al. Small bowel of patients with asthma and allergic rhinitis: absence of inflammation despite the presence of major cellular components of allergic inflammation. Allergy Asthma Proc. 2004;25:253–259.PubMed
11.
go back to reference Francis CY, Morris J, Whorwell PJ. The irritable bowel severity scoring system: a simple method of monitoring irritable bowel syndrome and its progress. Aliment Pharmacol Ther. 1997;11:395–402.PubMedCrossRef Francis CY, Morris J, Whorwell PJ. The irritable bowel severity scoring system: a simple method of monitoring irritable bowel syndrome and its progress. Aliment Pharmacol Ther. 1997;11:395–402.PubMedCrossRef
12.
go back to reference Kane SV, Sandborn WJ, Rufo PA, et al. Fecal lactoferrin is a sensitive and specific marker in identifying intestinal inflammation. Am J Gastroenterol. 2003;98:1309–1314.PubMedCrossRef Kane SV, Sandborn WJ, Rufo PA, et al. Fecal lactoferrin is a sensitive and specific marker in identifying intestinal inflammation. Am J Gastroenterol. 2003;98:1309–1314.PubMedCrossRef
14.
go back to reference Vanner SJ, Depew WT, Paterson WG, et al. Predictive value of the Rome criteria for diagnosing the irritable bowel syndrome. Am J Gastroenterol. 1999;94:2912–2917.PubMedCrossRef Vanner SJ, Depew WT, Paterson WG, et al. Predictive value of the Rome criteria for diagnosing the irritable bowel syndrome. Am J Gastroenterol. 1999;94:2912–2917.PubMedCrossRef
15.
go back to reference Zar S, Kumar D, Benson MJ. Food hypersensitivity and irritable bowel syndrome. Aliment Pharmacol Ther. 2001;15:439–449.PubMedCrossRef Zar S, Kumar D, Benson MJ. Food hypersensitivity and irritable bowel syndrome. Aliment Pharmacol Ther. 2001;15:439–449.PubMedCrossRef
16.
go back to reference Stefanini GF, Saggioro A, Alvisi V, et al. Oral cromolyn sodium in comparison with elimination diet in the irritable bowel syndrome, diarrheic type. Multicenter study of 428 patients. Scand J Gastroenterol. 1995;30:535–541.PubMedCrossRef Stefanini GF, Saggioro A, Alvisi V, et al. Oral cromolyn sodium in comparison with elimination diet in the irritable bowel syndrome, diarrheic type. Multicenter study of 428 patients. Scand J Gastroenterol. 1995;30:535–541.PubMedCrossRef
17.
go back to reference Stefanini GF, Prati E, Albini MC, et al. Oral disodium cromoglycate treatment on irritable bowel syndrome: an open study on 101 subjects with diarrheic type. Am J Gastroenterol. 1992;87:55–57.PubMed Stefanini GF, Prati E, Albini MC, et al. Oral disodium cromoglycate treatment on irritable bowel syndrome: an open study on 101 subjects with diarrheic type. Am J Gastroenterol. 1992;87:55–57.PubMed
18.
go back to reference Powell N, Huntley B, Beech T, et al. Increased prevalence of gastrointestinal symptoms in patients with allergic disease. Postgrad Med J. 2007;83:182–186.PubMedPubMedCentralCrossRef Powell N, Huntley B, Beech T, et al. Increased prevalence of gastrointestinal symptoms in patients with allergic disease. Postgrad Med J. 2007;83:182–186.PubMedPubMedCentralCrossRef
19.
go back to reference Jones MP, Walker MM, Ford AC, Talley NJ. The overlap of atopy and functional gastrointestinal disorders among 23,471 patients in primary care. Aliment Pharmacol Ther. 2014;40:382–391.PubMedCrossRef Jones MP, Walker MM, Ford AC, Talley NJ. The overlap of atopy and functional gastrointestinal disorders among 23,471 patients in primary care. Aliment Pharmacol Ther. 2014;40:382–391.PubMedCrossRef
20.
go back to reference Walker MM, Powell N, Talley NJ. Atopy and the gastrointestinal tract—a review of a common association in unexplained gastrointestinal disease. Expert Rev Gastroenterol Hepatol. 2014;8:289–299.PubMedCrossRef Walker MM, Powell N, Talley NJ. Atopy and the gastrointestinal tract—a review of a common association in unexplained gastrointestinal disease. Expert Rev Gastroenterol Hepatol. 2014;8:289–299.PubMedCrossRef
21.
go back to reference Barbara G, Stanghellini V, De Giorgio R, et al. Activated mast cells in proximity to colonic nerves correlate with abdominal pain in irritable bowel syndrome. Gastroenterology. 2004;126:693–702.PubMedCrossRef Barbara G, Stanghellini V, De Giorgio R, et al. Activated mast cells in proximity to colonic nerves correlate with abdominal pain in irritable bowel syndrome. Gastroenterology. 2004;126:693–702.PubMedCrossRef
22.
go back to reference Valeur J, Norin E, Midtvedt T, Berstad A. Assessment of microbial fermentation products in fecal samples. Neurogastroenterol Motil. 2010;22:1147.PubMedCrossRef Valeur J, Norin E, Midtvedt T, Berstad A. Assessment of microbial fermentation products in fecal samples. Neurogastroenterol Motil. 2010;22:1147.PubMedCrossRef
23.
go back to reference Barrett JS, Gearry RB, Muir JG, et al. Dietary poorly absorbed, short-chain carbohydrates increase delivery of water and fermentable substrates to the proximal colon. Aliment Pharmacol Ther. 2010;31:874–882.PubMed Barrett JS, Gearry RB, Muir JG, et al. Dietary poorly absorbed, short-chain carbohydrates increase delivery of water and fermentable substrates to the proximal colon. Aliment Pharmacol Ther. 2010;31:874–882.PubMed
24.
go back to reference Simren M. IBS with intestinal microbial dysbiosis: a new and clinically relevant subgroup? Gut. 2014;63:1685–1686.PubMedCrossRef Simren M. IBS with intestinal microbial dysbiosis: a new and clinically relevant subgroup? Gut. 2014;63:1685–1686.PubMedCrossRef
25.
go back to reference Melchior C, Gourcerol G, Dechelotte P, Leroi AM, Ducrotte P. Symptomatic fructose malabsorption in irritable bowel syndrome: a prospective study. United Eur Gastroenterol J. 2014;2:131–137.CrossRef Melchior C, Gourcerol G, Dechelotte P, Leroi AM, Ducrotte P. Symptomatic fructose malabsorption in irritable bowel syndrome: a prospective study. United Eur Gastroenterol J. 2014;2:131–137.CrossRef
27.
go back to reference Reginald K, Westritschnig K, Werfel T, et al. Immunoglobulin E antibody reactivity to bacterial antigens in atopic dermatitis patients. Clin Exp Allergy. 2011;41:357–369.PubMedPubMedCentralCrossRef Reginald K, Westritschnig K, Werfel T, et al. Immunoglobulin E antibody reactivity to bacterial antigens in atopic dermatitis patients. Clin Exp Allergy. 2011;41:357–369.PubMedPubMedCentralCrossRef
28.
go back to reference Klooker TK, Braak B, Koopman KE, et al. The mast cell stabiliser ketotifen decreases visceral hypersensitivity and improves intestinal symptoms in patients with irritable bowel syndrome. Gut. 2010;59:1213–1221.PubMedCrossRef Klooker TK, Braak B, Koopman KE, et al. The mast cell stabiliser ketotifen decreases visceral hypersensitivity and improves intestinal symptoms in patients with irritable bowel syndrome. Gut. 2010;59:1213–1221.PubMedCrossRef
Metadata
Title
Functional Gastrointestinal Symptoms Are Associated with Higher Serum Total IgE Levels, but Less Atopic Sensitization
Authors
Ellen Johanne Vara
Cecilie Svanes
Trude D. Skorge
Aud Berstad
Erik Florvaag
Debbie Jarvis
Ernst Omenaas
Marie Waatevik
Ane Johannessen
Gülen Arslan Lied
Publication date
01-01-2016
Publisher
Springer US
Published in
Digestive Diseases and Sciences / Issue 1/2016
Print ISSN: 0163-2116
Electronic ISSN: 1573-2568
DOI
https://doi.org/10.1007/s10620-015-3835-1

Other articles of this Issue 1/2016

Digestive Diseases and Sciences 1/2016 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine